Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.

Peter Dubsky; Paul Sevelda; Raimund Jakesz; Hubert Hausmaninger; Hellmut Samonigg; Michael Seifert; Ursula Denison; Brigitte Mlineritsch; Günther Steger; Werner Kwasny; Herbert Stöger; Rupert Bartsch; Michael Stierer; Susanne Taucher; Michael Fridrik; Walter Schippinger; Richard Greil; Richard Pötter; Michael Gnant

doi:10.1158/1078-0432.CCR-07-2068

Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.

Peter Dubsky, Paul Sevelda, Raimund Jakesz, Hubert Hausmaninger, Hellmut Samonigg, Michael Seifert, Ursula Denison, Brigitte Mlineritsch, Günther Steger, Werner Kwasny, Herbert Stöger, Rupert Bartsch, Michael Stierer, Susanne Taucher, Michael Fridrik, Walter Schippinger, Richard Greil (Co-author), Richard Pötter, Michael Gnant

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

31 Citations (Web of Science)

Original language	English
Pages (from-to)	2082-2087
Journal	CLINICAL CANCER RESEARCH
Volume	14
Issue number	7
DOIs	https://doi.org/10.1158/1078-0432.CCR-07-2068
Publication status	Published - 2008

Keywords

PRETREATMENT HEMOGLOBIN LEVELS
TREATMENT RESISTANCE
CARCINOMA
HYPOXIA
THERAPY
IMPACT
RADIOTHERAPY
OXYGENATION
LEVEL

Access to Document

10.1158/1078-0432.CCR-07-2068

Cite this

Dubsky, P., Sevelda, P., Jakesz, R., Hausmaninger, H., Samonigg, H., Seifert, M., Denison, U., Mlineritsch, B., Steger, G., Kwasny, W., Stöger, H., Bartsch, R., Stierer, M., Taucher, S., Fridrik, M., Schippinger, W., Greil, R., Pötter, R., & Gnant, M. (2008). Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy. CLINICAL CANCER RESEARCH , 14(7), 2082-2087. https://doi.org/10.1158/1078-0432.CCR-07-2068

Dubsky, Peter ; Sevelda, Paul ; Jakesz, Raimund et al. / Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy. In: CLINICAL CANCER RESEARCH 2008 ; Vol. 14, No. 7. pp. 2082-2087.

@article{d8ef5a80dbe041de8a1eb87e0872d97d,

title = "Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.",

keywords = "PRETREATMENT HEMOGLOBIN LEVELS, TREATMENT RESISTANCE, CARCINOMA, HYPOXIA, THERAPY, IMPACT, RADIOTHERAPY, OXYGENATION, LEVEL",

author = "Peter Dubsky and Paul Sevelda and Raimund Jakesz and Hubert Hausmaninger and Hellmut Samonigg and Michael Seifert and Ursula Denison and Brigitte Mlineritsch and G{\"u}nther Steger and Werner Kwasny and Herbert St{\"o}ger and Rupert Bartsch and Michael Stierer and Susanne Taucher and Michael Fridrik and Walter Schippinger and Richard Greil and Richard P{\"o}tter and Michael Gnant",

year = "2008",

doi = "10.1158/1078-0432.CCR-07-2068",

language = "English",

volume = "14",

pages = "2082--2087",

journal = "CLINICAL CANCER RESEARCH ",

issn = "1078-0432",

publisher = "Amer Assoc Cancer Research",

number = "7",

}

Dubsky, P, Sevelda, P, Jakesz, R, Hausmaninger, H, Samonigg, H, Seifert, M, Denison, U, Mlineritsch, B, Steger, G, Kwasny, W, Stöger, H, Bartsch, R, Stierer, M, Taucher, S, Fridrik, M, Schippinger, W, Greil, R, Pötter, R & Gnant, M 2008, 'Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.', CLINICAL CANCER RESEARCH , vol. 14, no. 7, pp. 2082-2087. https://doi.org/10.1158/1078-0432.CCR-07-2068

Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy. / Dubsky, Peter; Sevelda, Paul; Jakesz, Raimund et al.
In: CLINICAL CANCER RESEARCH , Vol. 14, No. 7, 2008, p. 2082-2087.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.

AU - Dubsky, Peter

AU - Sevelda, Paul

AU - Jakesz, Raimund

AU - Hausmaninger, Hubert

AU - Samonigg, Hellmut

AU - Seifert, Michael

AU - Denison, Ursula

AU - Mlineritsch, Brigitte

AU - Steger, Günther

AU - Kwasny, Werner

AU - Stöger, Herbert

AU - Bartsch, Rupert

AU - Stierer, Michael

AU - Taucher, Susanne

AU - Fridrik, Michael

AU - Schippinger, Walter

AU - Greil, Richard

AU - Pötter, Richard

AU - Gnant, Michael

PY - 2008

Y1 - 2008

KW - PRETREATMENT HEMOGLOBIN LEVELS

KW - TREATMENT RESISTANCE

KW - CARCINOMA

KW - HYPOXIA

KW - THERAPY

KW - IMPACT

KW - RADIOTHERAPY

KW - OXYGENATION

KW - LEVEL

U2 - 10.1158/1078-0432.CCR-07-2068

DO - 10.1158/1078-0432.CCR-07-2068

M3 - Original Article

C2 - 18381948

SN - 1078-0432

VL - 14

SP - 2082

EP - 2087

JO - CLINICAL CANCER RESEARCH

JF - CLINICAL CANCER RESEARCH

IS - 7

ER -

Dubsky P, Sevelda P, Jakesz R, Hausmaninger H, Samonigg H, Seifert M et al. Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy. CLINICAL CANCER RESEARCH . 2008;14(7):2082-2087. doi: 10.1158/1078-0432.CCR-07-2068